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Abstract 
Purpose of review 
Recognising the rising prevalence of heart failure in China, patients with heart failure have 
substantial palliative needs. This review highlights recent evidence on the epidemic of heart 
failure, identifies needs and potential benefit of palliative care in heart failure, and sets 
future strategic policy and research directions in China.   
Recent findings 
Epidemiological studies demonstrate the prevalence of heart failure among women is higher 
than men in China and increases substantially with age. However, few studies have 
addressed the palliative needs of Chinese heart failure patients. The main themes from this 
review include: (1) Healthcare providers should be culturally sensitive when assessing 
symptoms and needs. (2) Locally validated, brief outcome measures are called for to identify 
symptoms and needs of Chinese heart failure patients. (3) Palliative care should be better 
integrated into the management of heart failure through increased training for healthcare 
providers, policy development, financial support, and cultural acceptance of palliative care.  
Summary 
Large-scale epidemiological studies are urgently needed to assess the current situation of 
heart failure in China, alongside interventional studies to drive the development of 
innovative palliative care services to address the needs of Chinese heart failure patients. 
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INTRODUCTION  
Cardiovascular disease has become the leading cause of death for Chinese accounting for 
44.8% of deaths in rural and 41.9% in urban area, due to a dramatic shift from a traditional 
to a more ‘Western’ lifestyle, rapid urbanisation/industrialisation, and aging [1, 2]. Heart 
failure (HF) is a major healthcare concern with an estimated prevalence of more than 26 
million cases worldwide [3*, 4]. HF in China is recognised as a dominant form of 
cardiovascular disease, associated with high morbidity and mortality [5*, 6]. China is now 
facing a rising epidemic of HF, which has serious socioeconomic consequences [7].  
 
The prevention and care of HF in China should be elevated to a national public policy priority 
[8]. One way to meet the needs of HF patients and their families is through palliative care. 
However, palliative care in China still focuses primarily on cancer patients and remains 
underutilised with those with non-cancer conditions [9*]. Furthermore, little is known about 
the palliative needs of Chinese HF patients. It is imperative to review recent evidence on the 
trend of the epidemic of HF, identify needs and potential benefit of palliative care in HF, and 
set strategic directions for public health policies and future research in China.  
 
EPIDEMIOLOGY OF HEART FAILURE IN CHINA 
The cause of HF in China has shifted significantly from rheumatic valvular disease in the 
1980s to coronary heart disease now [10, 11], which is consistent with the results of 
investigations analysing evolving trends in the epidemiological factors and treatment of 
hospitalised patients with congestive HF in Shanghai during 1980, 1990, and 2000 based on 
case records of 2,178 patients (mean age 64.0 ± 16.0 years). They found the rate of HF due 
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to rheumatic heart disease decreased from 46.8% to 8.9%, and that due to coronary heart 
disease rose from 31% to 55.7% [12].  
 
A recent review [13] highlighted important epidemiological studies of HF in China. The first 
and only available national survey of 15,518 adults (aged 35-74 years) from 10 provinces 
was conducted in 2001 to investigate the prevalence and geographic variation of self-
reported congestive HF in China [14]. It showed that the prevalence of HF is 0.9% for the 
general population (lower than Western countries – 1.2-2.0%), 0.7% for males, and 1.0% for 
females. Approximately 4 million people in China were estimated to have HF, with a 
prevalence of 0.4% in people aged 35-44 years rising to 1.0% in those aged 45-54 years, and 
to 1.3% in those aged more than 55 years. The survey demonstrated that the risk of chronic 
HF was higher in northern China (1.4%) than in southern China (0.5%), and higher in urban 
(1.1%) than in rural areas (0.8%). HF is becoming more prevalent in China especially in older 
people, which imposes a significant socioeconomic burden on individual patients/families, 
and demands an increasing proportion of healthcare resources to deal with burgeoning 
rates of hospital admissions/readmissions, disability and mortality, [15*, 16*].  
 
As the aged population grows rapidly in China, the prevalence, morbidity, and mortality of 
HF will continue to increase [17]. Unlike Western countries, the prevalence of HF among 
women is higher than men in China. The prevalence of congestive HF increases substantially 
with age, which is consistent with data from other countries [14]. Although the causes of HF 
vary between cities in China, coronary heart disease, hypertension, rheumatic valvular 
disease and cardiomyopathy have been recognised as major causes [18]. In addition, reliable 
data on disease prevalence and incidence of HF in the Asian-Pacific region are lacking [3*]. 
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Epidemiological data on HF in China is relatively old and is an inappropriate base on which 
to develop prevention and management strategies.  
 
SYMPTOMS AND QUALITY OF LIFE AMONG HEART FAILURE PATIENTS IN CHINA 
Symptom/needs assessment plays a vital role in measuring health status or quality of life in 
HF [19, 20]. Although the high prevalence and poor prognosis associated with HF has 
attracted increasing attention [8], new evidence on symptom/needs assessment at an 
individual level is lacking for Chinese patients. A review from an Asian-Pacific perspective 
suggests that patients with HF from this region are younger and have more severe 
signs/symptoms than those in Western counties [3*]. Recently, a secondary analysis of a 
cross-sectional observational study was conducted to compare patients’ reporting of 
symptoms in HF between a Western (United States) and an Eastern Asian population 
(China/Taiwan) [21**]. Interestingly, the results showed that HF patients in China/Taiwan 
had significantly lower scores than those in the United States across six of eight symptoms 
analysed: Oedema (t = 2.995, p = .003), fatigue/increased need to rest (t = 3.841, p < .001), 
fatigue/low energy (t = 5.881, p < .001), shortness of breath (t = 6.403, p < .001), anxiety (t = 
2.425, p = .016), and feeling depressed (t = 2.723, p = .007).  
 
This study [21**] highlighted that it is unlikely the Eastern Asian population actually had a 
lower symptom burden as the two comparative groups had similar characteristics. One 
possibility could be a cultural difference between Western and Asian patients in reporting 
symptoms. This is consistent with previous studies documenting that people of an Asian 
ethnic background often exhibited lower levels of self-disclosure, emotional distress and 
symptom severity, and were more prone to mask their feelings [17, 22, 23]. Another 
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qualitative study among cancer patients also reported that Asian patients tended to 
minimise and normalise their symptoms to avoid worrying or burdening their families [24]. 
These findings emphasise that symptom reporting reflects the context of the individual’s 
cultural and personal situation [25, 26], and therefore, healthcare providers should be 
culturally sensitive when clinically assessing patients [27].  
 
Two questionnaires are commonly used when assessing the quality of life of those with HF 
in China: the Minnesota Living with Heart Failure Questionnaire (MLHFQ) and Chinese 
Quality of Life instrument (ChQoL) [8]. The MLHFQ contains 21 items and is a 
psychometrically validated measure assessing health-related quality of life in HF patients [28, 
29]. The Chinese version of the MLHFQ has been developed and shown to be satisfactory 
and comparable to the English version [30, 31]. It was used in the cross-cultural study 
described above [21**] and also in a small single-centre study of 66 Chinese patients with 
chronic HF, demonstrating a significant correlation between disease severity and quality of 
life; the more severe the disease, the higher the questionnaire score [32]. These results are 
consistent with those from a previous study conducted in the United States showing the 
questionnaire to be generally sensitive to symptom severity [33].  
 
ChQoL was initially developed based on the concept of health in Traditional Chinese 
Medicine and proved to be a well validated generic, self-reported health status instrument 
[34]. It has been used with Chinese HF patients [35, 36]. A small study of 39 in-patients with 
congestive HF who had undergone treatment with integrative Chinese medicine found that 
all domains of the ChQoL showed significant improvement after treatment, and the ChQoL 
was demonstrated to be more responsive to measuring changes in quality of life than two 
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generic questionnaires - World Health Organisation Quality of Life assessment short form 
(WHOQOL-BREF) and the Short Form 36-item Health Survey (SF-36), but less responsive 
than the disease-specific questionnaire - MLHFQ [36]. Although these results suggest that 
the ChQoL could be considered suitable as an outcome measure for Chinese patients with 
congestive HF, it may be impractical given the complexity of the questionnaire: 50 items 
across physical/spiritual/emotional domains which require 10 - 20 minutes to complete. 
Locally validated and brief outcome measurement tools are urgently needed to identify HF 
patients’ needs and evaluate services in China.   
 
WHAT CAN PALLIATIVE CARE OFFER FOR HEART FAILURE PATIENTS IN CHINA? 
Palliative care has been increasingly recognised as playing an important role along the 
cancer disease trajectory [37-39]. It is believed that a palliative care approach is also 
important in patients with HF, even upstream from the end of life phase [40, 41]. Palliative 
care helps to meet the multidimensional needs of patients and their families. For example, 
in a cluster randomised trial involving 434 patients in Norway, a palliative care intervention 
based on consultations with palliative care providers resulted in an increased likelihood of 
dying at home [42].  
 
Experts and the public increasingly call for the expansion of palliative care to accommodate 
patients with HF in the provision of patient access to continuous, coordinated, and high 
quality palliative care given simultaneously with specialist cardiology care [41]. Many 
professional and policy organisations such as the American Heart Association (AHA) and 
American College of Cardiology Foundation (ACCF) have published guidelines 
recommending the integration of palliative care in the treatment of patients with advanced 
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HF [43],  emphasising the potential benefits of supportive and palliative care in the 
alleviation of symptoms and improved quality of life [44]. However, to date the 
incorporation of palliative care into the management of HF has been inconsistent for several 
reasons: the uncertainty intrinsic to the HF disease trajectory with an overlay of comorbidity 
and frailty, complexities of communication between healthcare providers and patients 
manifest in silos of care, the use of life saving devices with complex trade-offs, a lack of 
knowledge about palliative/hospice care,  and a limited evidence base [41, 45]. 
 
In general, palliative care provision in China is patchy and coverage is poor. According to the 
2015 Quality of Death Index, China ranked 71 out of 80 countries, and was reported to be 
“facing difficulties from slow adoption of palliative care and a rapidly aging population” [46]. 
Four main barriers have been recognised as limiting the development of palliative care in 
China: a traditional view towards palliative care, financial costs, the absence of national 
strategies and guidelines, and a severe shortage of professional palliative care staff [9*, 47*]. 
Palliative care in China still remains underutilised for patients with non-cancer diagnoses 
[9*]. Although the Chinese government has tried to tackle these issues through policy 
development, financial support and educational initiatives, the development and spread of 
effective models of palliative care to meet the needs of Chinese patients has a long way to 
go.    
 
People with advanced HF often suffer complex multiple symptoms and psychosocial distress 
because of the nature of their illness and mortality risk [48, 49]. There are numerous 
international studies describing the experiences/needs of patients living and dying with HF 
[50-52]. Their families may provide day-to-day care, but are also subject to their own 
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anxieties, concerns, and potential losses. Palliative care should consider the patient/family 
dyad  as a single unit of care, and support family/informal carers/friends throughout the 
disease trajectory and into bereavement. However, palliative care is often perceived as 
limited to comfort care at the end of life, and due to this misconception, it is not requested 
by the patient/family earlier in the disease course [53]. The provision of effective palliative 
care to those affected by HF in China demands a multidisciplinary approach in addressing 
psychosocial and spiritual concerns in a culturally sensitive manner, supporting medication 
management and financial concerns, and ensuring that the treatment plan is aligned with 
the goals of care of both patients and families [54].   
 
FUTURE DIRECTIONS 
The access and provision of palliative care in China varies significantly across health 
conditions, geographical locations, and service providers [9*, 47*]. In order to improve 
palliative care provision for HF patients, several objectives should be met:  
 
Firstly, there are few data documenting the epidemiology of HF, or patients’ needs in China. 
Large-scale epidemiological studies are needed to provide a reliable evidence base to inform 
better HF management, and intervention studies are required to investigate the 
effectiveness of innovative palliative interventions including Chinese herbal medicine [55]. It 
is important to conduct high quality clinical studies to assess symptoms/needs and to 
capture problems/concerns through valid patient-centred outcome measures such as the 
Integrated Palliative care Outcome Scale (IPOS) [56*]. The IPOS translation and validation 
will be launched in 2018 through collaborations with the Beijing Cancer Hospital. A disease-
specific measure – IPOS HF in Chinese may be the next logical step.  
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Secondly, professional and policy organisations must emphasise and incentivise palliative 
care provision, including end of life care. Although the Chinese Society of Cardiology, part of 
the Chinese Medical Association, in recently updating the 2002 chronic HF guidelines did not 
explicitly mention palliative care, it did highlight the importance of prevention and 
encouraged a broader range of treatment options to improve patient outcomes [57].  
 
Third, putting people before the disease is key to ensuring patient-centred palliative care. 
Palliative care is about meeting multidimensional needs including information needs [58**-
60]. Patients’ beliefs and norms within a culture can affect their perception of symptoms, 
their response, and what they report to healthcare providers [21**]. Therefore, clinicians 
should be aware of the cultural symbolism and the meaning attached to symptoms when 
assessing patients [61**]. Responsiveness of the health care system is crucial such as 
working across services, providing good information, and responding flexibly to the 
individual's needs [62, 63].  
 
Finally, effective integration of palliative care into the management of HF requires enhanced 
training of healthcare providers, particularly on the nature of palliative care, elucidating 
patients’ values, goals / preferences, and advance care planning within the ethos of shared 
decision making. In addition, cultural acceptance of palliative care is crtitical. If death is 
consistently viewed as failure rather than an important chapter of natural life, this will 
continue to impact the adoption of palliative care in China [9*]. Educational programmes for 
patients/families, healthcare providers, and the wider public could set the scene for 
attitudinal change.  
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CONCLUSION  
HF presents a great public health challenge to China due to its changing economic 
circumstances and aging population. Palliative care has clear applications to HF through its 
focus on complex symptom management, communication, shared decision making, and 
advance care planning. Importantly, it provides a support system to help families cope 
during illness and bereavement. However in China, palliative care still remains a neglected 
area. Considerable effort is needed to bolster the evidence base for palliative care 
interventions in HF, to develop outcome measurement and communication training, and 
ultimately, to change the culture and traditional views towards palliative care in China.  
 
KEY POINTS  
• There is an urgent need to conduct large-scale epidemiological studies to assess the 
current situation and overall trends of heart failure in China, which will provide a 
scientific foundation for more effective prevention and management strategies. 
• Patients’ reporting of symptoms relies on the context of the individual’s cultural and 
personal situation, therefore, healthcare providers should be culturally sensitive to 
assess patients’ symptoms and meet their needs.  
• Locally validated and practical outcome measurement tools such as the Integrated 
Palliative care Outcome Scale (IPOS) are urgently needed to identify Chinese patients’ 
symptoms and needs, and to evaluate palliative care services.  
• Better integration of palliative care into the management of heart failure requires 
increased training for healthcare providers, policy development, financial support, and 
cultural acceptance of palliative care in China.  
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• As the burden of heart failure in China is substantial and is becoming an important 
public health issue, high quality studies are urgently needed to investigate the 
effectiveness of novel palliative care interventions to address the needs of Chinese heart 
failure patients and their families.  
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